Home › Lupus › New York › Syracuse
Lupus clinical trials in Syracuse, NY
5 studies for Lupus are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50241, Syracuse
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, Syracuse
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
RecruitingPhase 2
- State University of New York Upstate Medical Center (SUNY), Syracuse
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
RecruitingPhase 1/2Healthy volunteers welcome
- US08-0, Syracuse
Lupus Landmark Study: A Prospective Registry and Biorepository
RecruitingObservational study
- SUNY Upstate, Syracuse
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Santa Monica, CA8 studies
- Oklahoma City, OK8 studies
- Boston, MA8 studies
- Los Angeles, CA8 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Non-Muscle Invasive Bladder Cancer8 studies
- Endometrial Cancer7 studies
- Ovarian Cancer7 studies
- Lung Cancer6 studies
- Obesity6 studies
- Colorectal Cancer5 studies
- Type 2 Diabetes5 studies
- Speech Sound Disorder5 studies
- Breast Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.